Novavax Inc
NASDAQ:NVAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novavax Inc
NASDAQ:NVAX
|
US |
|
W
|
WSP Global Inc
OTC:WSPOF
|
CA |
|
Amalgamated Bank
F:A0B0
|
US |
|
Bank Rakyat Indonesia (Persero) Tbk PT
F:BYRA
|
ID |
|
O
|
Occidental Petroleum Corp
XMUN:OPC
|
US |
|
Amalgamated Bank
NASDAQ:AMAL
|
US |
|
S
|
Seabridge Gold Inc
XMUN:SRM
|
CA |
Wall St Price Targets
NVAX Price Targets Summary
Novavax Inc
According to Wall Street analysts, the average 1-year price target for NVAX is 14.39 USD with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVAX's stock price target?
Price Target
14.39
USD
According to Wall Street analysts, the average 1-year price target for NVAX is 14.39 USD with a low forecast of 7.07 USD and a high forecast of 26.25 USD.
What is the Revenue forecast for Novavax Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 0%.
What is the Gross Profit forecast for Novavax Inc?
Projected CAGR
-31%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 46%. The projected CAGR for the next 3 years is -31%.
What is the Operating Income forecast for Novavax Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 8 years is 2%.
What is the Pre-Tax Income forecast for Novavax Inc?
Projected CAGR
-41%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -41%.
What is the Net Income forecast for Novavax Inc?
Projected CAGR
-21%
The compound annual growth rate for Net Income over the next 7 years is -21%.
